Nuclear Medicine: Page 57

Lantheus posts lower Q3 results
By AuntMinnie.com staff writers
Lantheus Medical Imaging parent company Lantheus Holdings posted lower revenues and net income for its third quarter of 2019.
October 30, 2019
2019 10 31 18 11 2421 Graph Financial Results Tablet 400
Navidea highlights rheumatoid arthritis results
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals said that interim analysis of an ongoing phase IIB study shows positive results from using its technetium-99m tilmanocept radiopharmaceutical in patients with rheumatoid arthritis.
October 29, 2019
2019 10 30 17 20 8741 Hands Arthritis2 400
Hermes gets FDA clearance for radiation dose software
By AuntMinnie.com staff writers
Hermes Medical Solutions has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Voxel Dosimetry software for estimating radiation dose in nuclear medicine studies.
October 22, 2019
2018 12 11 00 02 7009 Atom Nuclear Lab 400
NRC accepts Shine's operating application
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) has accepted an operating license application from Shine Medical Technologies for the company's planned medical isotope production facility in Janesville, WI.
October 14, 2019
2018 12 11 00 02 7009 Atom Nuclear Lab 400
Shine forms therapeutics division
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies has launched Shine Therapeutics, a new division that will target the market for therapeutic isotopes.
October 13, 2019
2016 09 13 17 07 43 134 Atomic Technology 400
Biodex joins forces with Canadian shielding firm
By AuntMinnie.com staff writers
Medical imaging accessory supplier Biodex Medical Systems has formed a strategic partnership with isotope shielding technology provider South West Exposures of Canada for the theranostics and nuclear medicine markets.
October 13, 2019
2018 04 24 20 24 4264 Isotope 400
IBA and CAMH partner to build nuclear medicine program
By AuntMinnie.com staff writers
Proton therapy developer Ion Beam Applications (IBA) and Azrieli Centre for Neuro-Radiochemistry at CAMH (Centre for Addiction and Mental Health) in Toronto have entered into a long-term agreement to promote nuclear medicine via R&D and a clinical program.
October 10, 2019
2019 09 21 00 44 1021 Iba Astro 2019
Sofie signs deal with ABX for cGMP compliance
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has signed an agreement with ABX Advanced Biochemical Compounds of Radeberg, Germany, for ABX to provide Sofie with current good manufacturing practice (cGMP) precursor and reference standards for Sophie's fibroblast activation protein inhibitor compounds.
October 9, 2019
GE, Theragnostics partner on PSMA agent
By AuntMinnie.com staff writers
GE Healthcare and Theragnostics have signed a global partnership to develop a new prostate-specific membrane antigen (PSMA) PET/CT imaging agent.
October 8, 2019
2016 10 04 11 38 34 158 Prostate 400
ImaginAb touts research on T-cell PET imaging agent
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb said data from the first-in-human imaging study of its CD8 T-cell PET agent for use in detecting solid malignancies were published online October 4 in the Journal of Nuclear Medicine.
October 7, 2019
2018 11 06 23 34 9504 Pet Scan Patient 400
AuntMinnie.com Molecular Imaging Insider
By Wayne Forrest
October 7, 2019
Shine secures $50M in financing
By AuntMinnie.com staff writers
Medical isotope firm Shine Medical Technologies has secured $50 million in financing with funds managed by Oaktree Capital Management of Los Angeles.
October 7, 2019
2016 09 13 17 07 43 134 Atomic Technology 400
Previous Page
Page 57 of 445
Next Page